Ausgewählte Publikationen
Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I, Tardio LBartolomeo, Hofmann U, Ghallab A, Hengstler JG, Führer D, Zwanziger D.
2021. Thyroid 31(6):973–984. doi: 10.1089/thy.2020.0636
Thyroid Hormone Deficiency Modifies Hepatic Lipid Droplet Morphology and Molecular Properties in Lithogenic-Diet Supplemented Mice.
Kube I, Jastrow H, Führer D, Zwanziger D.
2021. Endocrinol Diabetes 129(12):926–930. doi: 10.1055/a-1404-7939
Thyroid Dysfunction and Cholesterol Gallstone Disease.
Kube I, Zwanziger D.
2020. Endocrinol Diabetes 128(6-07):455-461. doi: 10.1055/a-1033-7273
Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism.
Badziong J, Ting S, Tiedje V, Brix K, Brabant G, Möller LC, Schmid KW, Führer D, Zwanziger D.
2017. Eur J Endocrinol 177(3):243-250. doi: 10.1530/EJE-17-0279
The long N-terminus of the human monocarboxylate transporter 8 is a target of ubiquitin-dependent proteasomal degradation which regulates protein expression and oligomerization capacity.
Zwanziger D*, Schmidt M*, Fischer J, Kleinau G, Braun D, Schweizer U, Möller LC, Biebermann H, Führer D. *equal contribution.
2017. Mol Cell Endocrinol 434:278-87. doi: 10.1016/j.mce.2016.05.017
The impact of claudin-1 on follicular thyroid carcinoma aggressiveness.
Zwanziger D*, Badziong J*, Ting S, Möller LC, Schmid KW, Siebolts U, Wickenhauser C, Dralle H, Führer D. *equal contribution.
2015. Endocr Relat Cancer 22(5):819-30. doi: 10.1530/ERC-14-0502
